Evaluation of pulmonary tuberculosis case detection improvement with the deployment of XpertMTB/Rif in the tuberculosis control program of cross River State, Nigeria | Zendy

ErnestAfu Ochang | Zendy; UbleniE Emanghe | Zendy; Atana Ewa | Zendy; Akaninyene Otu | Zendy; JonahB Offor | Zendy; Michael Odo | Zendy; Aniekan Etokidem | Zendy; Barinadaa Afirima | Zendy; OjuEni Owuna | Zendy; SundayM Obeten | Zendy; MartinM Meremikwu | Zendy

Open Access

Evaluation of pulmonary tuberculosis case detection improvement with the deployment of XpertMTB/Rif in the tuberculosis control program of cross River State, Nigeria

Author(s) -

ErnestAfu Ochang,

UbleniE Emanghe,

Atana Ewa,

Akaninyene Otu,

JonahB Offor,

Michael Odo,

Aniekan Etokidem,

Barinadaa Afirima,

OjuEni Owuna,

SundayM Obeten,

MartinM Meremikwu

Publication year - 2017

Publication title -

international journal of mycobacteriology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.53

H-Index - 20

eISSN - 2212-554X

pISSN - 2212-5531

DOI - 10.4103/2212-5531.201890

Subject(s) - medicine , tuberculosis , sputum , human immunodeficiency virus (hiv) , mycobacterium tuberculosis , pulmonary tuberculosis , rifampicin , surgery , gastroenterology , veterinary medicine , virology , pathology

Global indices show that Nigeria has the highest tuberculosis (TB)-related mortality rate. Overdependence on Ziehl-Neelsen (ZN) smear microscopy for diagnosis and human immunodeficiency virus (HIV)/AIDS has limited control efforts. The new polymerase chain reaction-based XpertMTB/Rif (Cepheid Inc., CA, USA), which detects Mycobacterium tuberculosis and rifampicin resistance, was introduced in Cross River State in 2014. We evaluated the increment in pulmonary TB case detection following introduction of XpertMTB/Rif into the Cross River State TB control program.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research